Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-24-023613

Chief Commercial Officer sold 5,088 shares at $25.47 ($129,591)

  • Chief Commercial Officer acquired 14,518 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wise John Drayton · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-13 Grant or award : show line 1 in the form +14,518 128,347 D
2024-05-14 Sale : show line 2 in the form −5,088 $25.47 $129,591 123,259 D
Open-market sales · 5,088 sh · avg $25.47 · $129,591

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-13 Grant or award : show line 3 in the form Stock Option (right to buy) +71,160 71,160 D
Loading xslF345X05/wk-form4_1715805527.xml…